Press Releases Novo Nordisk A/S OTC Markets

Equities

NONOF

DK0062498333

Market Closed - OTC Markets Other stock markets 01:28:31 29/06/2024 am IST			5-day change	1st Jan Change
145.4 ^USD	+1.48%		+4.75%	+41.81%

28/06	India plans incentives for diabetes, obesity drug makers in 2026, government official says	RE
28/06	NOVO NORDISK : UBS gives a Neutral rating	ZD

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss	26/06	GL
New US fill finish facility receives $4.1 billion investment	26/06	AQ
Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery	26/06	AQ
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline	24/06	GL
Novo Nordisk A/S - share repurchase programme	24/06	GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month	18/06	AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association	18/06	GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says	17/06	AQ
Novo Nordisk A/S - share repurchase programme	17/06	GL
Haemophilia drug could reduce treated bleeding episodes	13/06	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	11/06	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	11/06	AQ
Novo Nordisk A/S - share repurchase programme	10/06	GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06	AQ
Novo Nordisk A/S - share repurchase programme	03/06	GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ
Novo Nordisk A/S - share repurchase programme	27/05	GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	21/05	AQ
Novo Nordisk A/S - share repurchase programme	17/05	GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons	15/05	GL